Clinical and dosimetric factors of radiation-induced esophageal injury: Radiation-induced esophageal toxicity

Advanced Search

BPG is committed to discovery and dissemination of knowledge

Home / Archive / Volume 11, Issue 17

This Article

Citation of this article

Corresponding Author of This Article

Article-Type of This Article

Open-Access Policy of This Article

Times Cited Counts in Google of This Article

Number of Hits and Downloads for This Article

All Articles published online

Item

Count

PDF

266

HTML

2350

Tables (1-5)

187

Sum=2803

May 7, 2005 (publication date) through Nov 23, 2024

Times Cited of This Article

Journal Information of This Article

Publication Name

World Journal of Gastroenterology

ISSN

1007-9327

Publisher of This Article

Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA

Clinical Research

World J Gastroenterol. May 7, 2005; 11(17): 2626-2629
Published online May 7, 2005. doi: 10.3748/wjg.v11.i17.2626

Table 2 Concurrent chemotherapy agents used.

Patients (n)	Concurrent chemotherapy
25	Cisplatin and etoposide
4	Cisplatin
2	Cisplatin, etoposide, and gemcitabine
6	Cisplatin and 5-fluorouracil
1	Cisplatin and Navelbine
5	Cisplatin, Navelbine and gemcitabine
5	Carboplatin and Taxol
3	Gemcitabine
3	Taxotere

Citation: Qiao WB, Zhao YH, Zhao YB, Wang RZ. Clinical and dosimetric factors of radiation-induced esophageal injury: Radiation-induced esophageal toxicity. World J Gastroenterol 2005; 11(17): 2626-2629
URL: https://www.wjgnet.com/1007-9327/full/v11/i17/2626.htm
DOI: https://dx.doi.org/10.3748/wjg.v11.i17.2626